Why is Optixanthin better?
-
Naturally-sourced ingredients
Optixanthin sources natural ingredients from mother nature. These are plant-based, safe, and exhibit significant health benefits. We set the Gold Standard for the natural astaxanthin industry, recognized by USP verification, delivering quality as our promise to consumers. -
Carefully and synergistically formulated by a team of medical professionals
Based on clinically proven evidence, our team combines natural astaxanthin with other key nutrients to create innovative formulations tailored to your needs. -
Right daily dose for significant effectiveness
Clinical research recommends 5mg of natural astaxanthin daily as the minimum effective dosage. Each Optixanthin product is generously formulated with this minimum effective dose to deliver noticeable health benefits. -
Different dosage forms for different therapeutic endpoints
Optixanthin products use various dosage forms of natural astaxanthin to suit each formulation, ensuring enhanced absorption and bioavailability. -
Appropriate storage conditions
Optixanthin carefully selects delivery systems and packaging to protect astaxanthin during manufacturing, transport, and storage.
✔ Pioneers in Cultivation, Research and Production
AstaReal is the pioneer in developing natural astaxanthin as a nutrient ingredient and the first to produce it commercially. AstaReal leads the industry in research, safety, quality, technical innovation, and reliability.
✔ Excellence in Quality, Setting the Industry Standard
AstaReal sets the Gold Standard for natural astaxanthin, recognized by USP verification, and serves as the benchmark for quality in the industry.
✔ No. 1 for Safety and Efficacy
AstaReal is the #1 researcher in astaxanthin with 51% of clinical studies published in peer-reviewed journals, ensuring unmatched safety and efficacy.
| Study Type | Dosage | Duration | Participants |
|---|---|---|---|
| Long-term | 4 mg/day | 6 months | 40 participants |
| High-Dose | 16–40 mg/day | 4 weeks | 132 participants |
| High-Dose | 45 mg/day | 4 weeks | 22 participants |
Over 40 clinical studies were conducted with no adverse reactions reported. (As of May 2018, AstaReal Report)
